scispace - formally typeset
M

M.K. Bharti

Researcher at Indian Veterinary Research Institute

Publications -  29
Citations -  336

M.K. Bharti is an academic researcher from Indian Veterinary Research Institute. The author has contributed to research in topics: Mesenchymal stem cell & Biology. The author has an hindex of 9, co-authored 21 publications receiving 219 citations. Previous affiliations of M.K. Bharti include Indian Council of Agricultural Research.

Papers
More filters
Journal ArticleDOI

Mesenchymal stem cell‐conditioned media: A novel alternative of stem cell therapy for quality wound healing

TL;DR: It was found that allogenic and xenogenic application of MSCs‐CM significantly improved quality wound healing with minimal scar formation and can be used allogenically as well as xenogenically for quality wounds healing.
Journal ArticleDOI

Expression dynamics of HSP70 during chronic heat stress in Tharparkar cattle.

TL;DR: The present findings indicate that HSP70 is possibly involved in heat stress adaptive response in Tharparkar cattle and the biphasic expression pattern may be providing a second window of protection during chronic heat stress.
Journal ArticleDOI

Expression analysis of Toll like receptors and interleukins in Tharparkar cattle during acclimation to heat stress exposure

TL;DR: The present findings indicate that TLR 2/4 and IL 2/6 could possibly play a vital role in thermo tolerance in Tharparkar cattle during short term and long term heat stress exposure.
Journal ArticleDOI

Expression and localization of fibroblast growth factor (FGF) family in buffalo ovarian follicle during different stages of development and modulatory role of FGF2 on steroidogenesis and survival of cultured buffalo granulosa cells.

TL;DR: The findings indicate that FGF family members are expressed in a regulated manner in buffalo ovarian follicles during different stages of development where FGF2 may promote steroidogenesis and GC survival through autocrine and paracrine manner.
Journal ArticleDOI

An allogenic therapeutic strategy for canine spinal cord injury using mesenchymal stem cells.

TL;DR: Allogenic canine BMSCs can serve as potent therapeutic candidate in cell‐based therapies, especially for diseases like SCI, where the conventional medication is not so promising.